novamed 产品代理
novamed 产品代理
有三条不同的主要生产线：微生物培养基产品、诊断产品和研究产品。
准备好的即用培养基产品的基本批量生产包括170多种不同的配方，用于临床微生物学实验室筛选微生物存在、培养和鉴定微生物以及测试抗生素敏感性。
Novamed Ltd在尿液分析产品市场上占有稳固的地位，并继续在当地医疗诊断和研究产品市场上处于领先地位。Novamed的Dipstrick®/Chromostrick®/Diaslide®尿液培养设备是一种床旁设备，用于快速简单的UTI诊断。这是一种基于菌落颜色差异的分离、计数和直接/推定尿液中细菌污染的新方法。
Novamed的快速免疫诊断产品生产清单包括40多种不同的产品，用于快速诊断人类的传染病和不同生理状况。
Prepared culture media
Monoplates
Bi-plates
Tubed media
Bottled media
Culture Devices
for clinical use
for industrial use
Diagnostic Products Professional Use
Diagnostic Products For Home Use
Digital Health Products
Research products
There are three different main production lines: microbiology culture media products, diagnostic products and research products.
The basic mass production of prepared ready-to-use culture media products consists of more than 170 different formulations, used in clinical microbiology laboratories to screen for microbial presence, grow and identify microorganisms and test for antibiotic susceptibility.
Novamed Ltd holds a firm place on the market of urinalysis products and continues to be in the lead of the local market of medical diagnostic and research products. Novamed’s DipStreak®/ChromoStreak®/Diaslide® urine culture devices are the type of bed-site devices for fast and simple UTI diagnosis. This is a novel method of isolation, counting and direct/presumptive identification of bacterial contamination in urine based on the color differences between colonies. The use of urine culture devices in doctor’s offices, private clinics, hospitals and out-patient communities completely changes the concept of urine examination and allows to save both patient’s and personnel’s time. Additionally, the cost of the test is considerably reduced. DipStreak®/ChromoStreak®/Diaslide® are already FDA approved, CE marked and successfully used in many countries in all over the world including Israel, Russia, Ukraine, Italy, USA and Japan.
Novamed’s production list for rapid immunodiagnostic products consists of more than 40 different items, intended for rapid diagnosis of infectious diseases and different physiological conditions in humans. The end user sector is represented by the clinical laboratories, emergency rooms, and doctor’s offices in Israel, Italy, Germany, Belgium, Ireland, Poland, Czech Republic, Switzerland, Lithuania, Kenya, Russia, Moldova, Belarus, Georgia, and Ukraine.
The Uni-Sep line of products has modernized procedures for lymphocyte isolation and separation.
